Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 9/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16624908 | 0.91 | KCNA5 (0.53) | KCNA5ALDH1A1SMN1; SMN2NPSR1TDP1 | |
| SCHEMBL16624913 | 0.90 | KCNA5 (0.52) | KCNA5ALDH1A1LMNASMN1; SMN2NPSR1 | |
| SCHEMBL16624893 | 0.85 | MEN1 (0.48) | KCNA5ALDH1A1LMNASMN1; SMN2NPSR1 | |
| SCHEMBL12473253 | 0.85 | KCNA5 (0.65) | KCNA5ALDH1A1KMT2ATSHR | |
| SCHEMBL16624925 | 0.83 | ALDH1A1 (0.51) | ALDH1A1LMNASMN1; SMN2NPSR1HTT | |
| SCHEMBL9909376 | 0.83 | KCNA5 (0.64) | KCNA5ALDH1A1KMT2A | |
| SCHEMBL5522123 | 0.83 | KCNA5 (0.64) | KCNA5ALDH1A1KMT2A | |
| SCHEMBL16624896 | 0.81 | SLC22A1 (0.42) | KCNA5ALDH1A1LMNASMN1; SMN2NPSR1 | |
| SCHEMBL8535929 | 0.80 | KCNA5 (0.49) | KCNA5ALDH1A1LMNASMN1; SMN2TDP1 | |
| SCHEMBL16624914 | 0.79 | SMN1; SMN2 (0.47) | ALDH1A1LMNASMN1; SMN2TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | KCNA5 1303/4885ALDH1A1 236/4885LMNA 1058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.